Home Formulation Business Markets

Russia & CIS

Marksans Pharma is currently exporting its products to CIS and Russia. Our focus is to leverage our strengths in research, IP and manufacturing to build strategic alliances and to increase our presence and participation in these markets.

We remain committed to growing our presence in these markets by delivering high quality products at affordable prices and constantly upgrading our offerings. In addition, introduction of newer products in existing markets and entry in new territories will impel our growth in these markets.

  • Carboplatin inj
  • Cefepime 1 gm inj
  • Doxorubicin inj
  • Gemcitabine 200 mg inj
  • Ibuprofen 200, 400 mg SGC
  • Meropenem 1 gm inj
  • Orlistat
  • Paclitaxel 100, 260 mg inj
  • Cisplatin 10mg/10ml, 50mg/50ml Injection
  • Itraconazole 100mg Capsules
  • Atorvastatin Calcium 10, 20, 30 mg tabs
  • Paracetamol 50mg+chlorpheniramine maleate 50mg
  • Cod liver oil
  • Clotrimazole+ clindamicine phosphate
  • Saw palmetto extract 320mg
  • Atorvastatin 10mg+Ezetimibe 10mg
  • Sildenafil 25, 50, 100mg Tablets
  • Phenylephrine HCl 10mg +caffeine 150mg
  • Oncology
  • Cardiovascular
  • Gastroenterology
  • Dermatology
  • Antibiotics
  • Russia
  • Ukraine
  • Kazakhstan
  • Georgia
  • Moldova